Navigation Links
Enzalutamide adds 5 months survival in late-stage prostate cancer
Date:8/16/2012

Results of a phase III clinical trial of the drug Enzalutamide, published yesterday in the New England Journal of Medicine, show the drug extends life by an average five months in the most advanced stages of prostate cancer.

"This is a major advance. Not only do we see more survival benefit than from traditional chemotherapy, but the side effects of Enzalutamide are much lower. It provides both more benefit and less harm you get the quantification of more life, but also see quality of life improvements," says study co-author, Thomas Flaig, MD, medical director of the University of Colorado Cancer Center's Clinical Investigations Shared Resource and associate professor of medicine at the University of Colorado School of Medicine.

The study, known by the acronym AFFIRM, followed 1199 patients with prostate cancer that had progressed despite both hormonal and chemotherapy treatments, with 2/3 of patients receiving the drug Enzalutamide versus control. Median overall survival for patients in the treatment arm of the trial was 18.4 months compared to 13.6 months for patients in the placebo arm. In addition to prolonged survival, patients given Enzalutamide showed meaningful improvement in other measures including PSA blood levels, an increase from 3.0 months to 8.3 months in time until PSA progression, and an increase from 2.9 months to 8.3 months in overall progression-free survival.

The once-a-day oral drug works by blocking prostate cancer's ability to supply itself with androgens hormones including testosterone that otherwise drive the cancer's growth. It does this by binding to cancer cells' androgen receptors the waving tentacles on the outsides of cells that are designed to grab specific molecules as they float past. Enzalutamide plugs these receptors, removing their ability to grab androgen.

This out-competition for space in androgen receptors is not a new strategy. But when treated with existing anti-androgen dr
'/>"/>

Contact: Garth Sundem
garth.sundem@ucdenver.edu
University of Colorado Denver
Source:Eurekalert

Page: 1 2

Related medicine news :

1. June 2012 marks a milestone for International Urogynecology Associates as Dr. Robert D. Moore and Dr. John R. Miklos perform their 24th Neovagina Surgery in 24 months
2. New Drug Appears to Extend Survival in Advanced Prostate Cancer Patients
3. Study: Vaccine targets malignant brain cancer antigens, significantly lengthens survival
4. Spending more on trauma care doesnt translate to higher survival rates
5. UT MD Anderson study finds link between depressive symptoms and cancer survival
6. Depression Could Shorten Cancer Survival, Study Suggests
7. Coordinated Care Boosts Cardiac Arrest Survival: Study
8. New research seeks to improve survival for myeloma and lymphoma patients
9. Survival rates for premature babies in high-level NICUs are better than previously reported
10. HPV improves survival for African-Americans with throat cancer
11. Access to clinical trials drives dramatic increases in survival from childhood cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... New York, New York (PRWEB) August 30, 2014 ... and other incretin mimetic claims continue to move forward ... a statement issued by AstraZeneca PLC on July 31, ... have been named in 409 product liability claims that ... cancer. Court documents indicate that many of these claims ...
(Date:8/30/2014)... Calif. (PRWEB) August 30, 2014 Insomnia causes ... helps listeners understand how they unknowingly developed insomnia and the ... restful nights during. Tune in to the show at ... The show airs live on August 30, and will be ... information on programming, go to DrCarolFrancisTalkRadio.com. , "Insomnia ...
(Date:8/30/2014)... Grand Rapids, MI (PRWEB) August 30, 2014 ... Michigan residents, Forefront Dermatology is expanding with the addition ... Mich. Dr. David Hammond who has provided leading-edge skin ... practice with Forefront Dermatology. , “As a doctor, ... care they deserve. Through partnering with Forefront Dermatology, I’m ...
(Date:8/30/2014)... HealthDay Reporter FRIDAY, Aug. 29, 2014 (HealthDay ... broken bones or other orthopedic trauma shops around for additional ... patients and patients who had used narcotic painkillers previously were ... lead author Dr. Brent Morris, a shoulder and neck surgeon ... doctors aren,t talking to one another about the painkiller needs ...
(Date:8/30/2014)... 30, 2014 In today’s world, a good ... get. Snoring and sleep apnea (a medical problem where the ... their bed partners of the rest they need to face ... population snores and 20 million people in the United States ... diagnosed and treated; and of those treated, many cannot tolerate ...
Breaking Medicine News(10 mins):Health News:Byetta Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Settlements in More than 80 Cases 2Health News:Byetta Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Settlements in More than 80 Cases 3Health News:Sleepless Nights, Exhausting Days, Mental Fog – Relief for Insomnia With Clinical Psychologist Dr. Carol Francis 2Health News:Expanding Care at the Forefront of Dermatology 2Health News:'Doctor-Shopping' for Painkillers Common After Broken-Bone Surgery, Study Finds 2Health News:'Doctor-Shopping' for Painkillers Common After Broken-Bone Surgery, Study Finds 3Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3
... gloss, depth of image, and surface ... Texas, Oct. 22 Solvay Engineered Polymers,Inc., has ... in the,production of extruded sheet. The new ADDHERE(TM) ... layer onto a substrate of thermoplastic,polyolefin (TPO) for ...
... with Top Children,s Miracle Network Health Experts, SALT LAKE CITY, Oct. 22 /PRNewswire/, ... experts from 170 Children,s ... questions about Methicillin-resistant Staphylococcus Aureus ... to antibiotics, and other ...
... Chairman Howard Dean issued the following statement in response,to ... $46 billion,in war spending, for a total of $196 ... coverage to 10 million of America,s low income children:, ... to fund his war of,choice in Iraq but has ...
... There,s no proof cancer will spread to the ... (HealthDay News) -- Women diagnosed with breast cancer who ... other, healthy breast removed as a preventive measure. , ... mastectomy, more than doubled from 1998 to 2003, according ...
... 22 The start of the,patent lawsuit by VNUS(R) ... laser competitors, Diomed, AngioDynamics and Vascular,Solutions, has been delayed ... delay is due to a busy court calendar. A ... new trial start dates. At,the conference, the parties will ...
... 22 Dialysis Corporation,of America (Nasdaq: DCAI ... third,quarter 2007 earnings after the close of the ... of America owns and operates freestanding kidney,hemodialysis centers ... Carolina and Virginia, and provides in-hospital,dialysis services on ...
Cached Medicine News:Health News:New ADDHERE(TM) Adhesive Tie Layer Bonds Acrylic Cap Layers to Substrates of Thermoplastic Polyolefin (TPO) in Production of Sheet for Use in Thermoforming 2Health News:New ADDHERE(TM) Adhesive Tie Layer Bonds Acrylic Cap Layers to Substrates of Thermoplastic Polyolefin (TPO) in Production of Sheet for Use in Thermoforming 3Health News:New ADDHERE(TM) Adhesive Tie Layer Bonds Acrylic Cap Layers to Substrates of Thermoplastic Polyolefin (TPO) in Production of Sheet for Use in Thermoforming 4Health News:Children's Miracle Network Hospital Doctors On Call to Answer Questions About MRSA Infection 2Health News:More Women Choosing 'Preventive' Double Mastectomy 2Health News:More Women Choosing 'Preventive' Double Mastectomy 3Health News:Delay in Start of VNUS Patent Litigation and Court Ruling on Summary Judgment Motion 2Health News:Dialysis Corporation of America Announces Third Quarter 2007 Earnings Release Date 2
(Date:8/29/2014)... DALLAS , Aug. 29, 2014 /PRNewswire-iReach/ -- ... Crystallography Scanner Industry, 2009-2019 is a professional and ... X-Ray Crystallography Scanner industry . The report firstly ... including its classification, application and manufacturing technology. The ... of X-Ray Crystallography Scanner listing their product specification, ...
(Date:8/29/2014)... 2014  Chuma Holdings, Inc. (OTCBB:CHUM) (the "Company"), ... support services for the lawfully organized cannabis industry, ... approved the Company,s name and symbol change request. ... be known as Chuma Holdings, Inc. ... merger with the Company,s wholly-owned subsidiary, Chuma Holdings, ...
(Date:8/29/2014)... CHAPEL HILL, N.C. , Aug. 29, 2014 /PRNewswire/ ... Opinion Leaders (KOLs) can be the difference between a ... struggle to effectively map and stratify KOL targets – ... to build the type of strong relationships upon which ... recent research, savvy pharma companies have identified internal inconsistencies ...
Breaking Medicine Technology:X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 2X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 3X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 5CannaMed Announces Name Change and Trading Symbol Change 2CannaMed Announces Name Change and Trading Symbol Change 3Implementing a Strategic Thought Leader Management & Engagement System 2
... Technology, Inc. announced today that Joe Chaudoin and Chris ... Vice President of Sales for the Eastern and Western ... Joe Chaudoin has over 20 years of ... career at Codman and Ethicon-Endo Surgery (both Johnson & ...
... HILLS, Calif., Jan. 19, 2012  HealthTech Capital announced today ... A2 investor in Cadence Biomedical, Inc. The move underscores ... to fund innovative, early-stage companies. Other investors included Alliance ... Angels, and Wings. With a first close of $750,000 ...
Cached Medicine Technology:Zyga Technology, Inc. Makes Two Key Additions to the Sales Leadership Team 2HealthTech Capital Leads Series A2 With Over $300,000 Investment in Cadence Biomedical 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: